Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
0.7488
+0.0688 (10.12%)
At close: Aug 22, 2025, 4:00 PM
0.7600
+0.0112 (1.50%)
After-hours: Aug 22, 2025, 7:59 PM EDT
Klotho Neurosciences Employees
Klotho Neurosciences had 3 employees as of December 31, 2024. The number of employees increased by 2 or 200.00% compared to the previous year.
Employees
3
Change
2
Growth
200.00%
Revenue / Employee
n/a
Profits / Employee
-$3,784,634
Market Cap
45.96M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3 | 2 | 200.00% |
| Dec 31, 2022 | 1 | -2 | -66.67% |
| Dec 31, 2021 | 3 | 2 | 200.00% |
| Dec 31, 2011 | 1 | 0 | - |
| Dec 31, 2010 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
KLTO News
- 4 days ago - Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market - PRNewsWire
- 10 days ago - Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology - PRNewsWire
- 27 days ago - UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology - PRNewsWire
- 4 weeks ago - Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology - PRNewsWire
- 4 weeks ago - Klotho Neurosciences, Inc. Partners with AAVnerGene Inc. to Make Klotho's Gene Therapy Assets - PRNewsWire
- 5 weeks ago - Klotho Neurosciences, Inc. Regains Full Compliance with NASDAQ Minimum Closing Bid Price and Stockholder Equity Rules - PRNewsWire
- 6 weeks ago - Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease") - PRNewsWire
- 7 weeks ago - This Penny Stock Exploded 500% In June: What You Need To Know - Benzinga